Postmenopausal women, stratified by a peroxisome proliferator-activated receptor gamma-2 (PPARG) polymorphism, were given the following treatments in a random order with a 5w wash-out period: a 400mg ibuprofen tablet or a placebo tablet; both treatments were followed after 30min by a single acute dose of 0.4g alcohol per kg bw. Serum estrogen levels were measured before and at three timepoints after alcohol intake. It is hypothesized that the acute decrease in estrogen sulphate and other markers of estrogens after alcohol intake is modulated by ibuprofen and by PPARG genotype.
In a pilot human intervention trial we aimed to determine the effect of the PPARG Pro12Ala polymorphism and the PPARγ stimulator, Ibuprofen, on sex-hormone levels following alcohol intake in postmenopausal women. Seven women with PPARG Pro12Ala and 18 PPARG wildtype women were included.The study was performed as a randomised, double-blinded, placebo controlled 2x24 h crossover study. The volunteers were randomised to 1 of 2 groups who got the two treatments in different orders. Treatment 1 was a placebo tablet with water followed after 30min by an alcoholic drink providing 0,4g alcohol per kilogram bw and treatment 2 was an Ibuprofen tablet (400mg) with water followed by the same alcoholic drink. The two treatments were separated by a 5-7 weeks washout period. Alcohol was supplied as 7.7% ethanol in a lime-flavoured drink and was consumed over 15 min. EDTA-plasma was collected 40min before and 30, 60 and 90 min after ethanol intake as well as after 24 hours. Ibuprofen (400mg) was provided together with 100mL water 30min before the ethanol. Urine was collected throughout the 24 hour interval. Serum estrone, estrone sulphate, serum estrogen-binding globulin (SHBG), and ethanol were determined. It is hypothesized that the acute decrease in estrogen sulphate and other markers of estrogens after alcohol intake is modulated by ibuprofen and by PPARG genotype.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Enrollment
25
400mg ibuprofen is provided and an alcohol challenge (0.4g/kg bw) is given 30min later
A placebo tablet is provided and an alcohol challenge (0.4g/kg bw) is given 30min later
Department of Nutrition, Exercise and Sports, University of Copenhagen
Frederiksberg, Denmark
Serum estrone sulphate (pmol/l)
Plasma estrone sulfate concentration after acute ethanol intake by Ibuprofen intake and/or PPARG genotype
Time frame: from 40 min before to 90 min after alcohol consumption
Serum estrone (pmol/l)
Plasma estrone decrease after acute ethanol intake by ibuprofen intake and/or PPARG genotype
Time frame: from 40 min before to 90 min after alcohol consumption
Serum SHBG (nmol/l)
Plasma SHBG concentration after acute ethanol ingestion by ibuprofen intake and/or PPARG genotype
Time frame: from 40 min before to 90 min after alcohol consumption
Serum ethanol (g/l)
Plasma ethanol concentration after acute ethanol ingestion
Time frame: from 40 min before to 90 min after alcohol consumption
Serum metabolomics (relative metabolite intensity)
The plasma metabolome profile by time after alcohol intake
Time frame: from 40 min before to 24h after alcohol intake
Urine metabolomics (relative metabolite intensity)
The urine metabolome profile by time after alcohol intake
Time frame: from 40 min before to 24h after alcohol intake
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.